The Neuroblastoma ALK(I1250T) Mutation Is a Kinase-Dead RTK In Vitro and In Vivo

Christina Schönherr(Umeå University), Bengt Hallberg(University of Gothenburg)
Translational Oncology
August 1, 2011
10.1593/tlo.11139
Cited by 37

Related Papers

Cell culture and<i>Drosophila</i>model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
|Disease Models & Mechanisms|2012|60
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
|Molecular Case Studies|2018|48
Phosphoproteomic analysis of anaplastic lymphoma kinase (<scp>ALK</scp>) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated <scp>ALK</scp> in neuroblastoma cells
|FEBS Journal|2013|47
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways
|Science Signaling|2018|40
Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation
|Cancers|2017|19